Michael Fons
Corporate Officer/Principal bij University of Texas Medical Branch
Actieve functies van Michael Fons
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| University of Texas Medical Branch | Corporate Officer/Principal | - | - |
Loopbaan van Michael Fons
Eerdere bekende functies van Michael Fons
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Vical, Inc.
 Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01-01-2004 | 01-01-2004 |
| INOVIO PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-06-2004 | - |
Statistieken
Internationaal
| Verenigde Staten | 4 |
Operationeel
| Corporate Officer/Principal | 3 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| INOVIO PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Health Technology |
- Beurs
- Insiders
- Michael Fons
- Ervaring
